These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11443938)

  • 1. [Synthesis, immunogenicity and antigenic characteristics of the glycoprotein E fragments from the tick-borne encephalitis virus].
    Volkova TD; Vol'pina OM; Zhmak MN; Ivanov VT; Vorovich MF; Timofeev AV
    Bioorg Khim; 2001; 27(3):174-9. PubMed ID: 11443938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the antigenic structure of tick-borne encephalitis virus using synthetic peptides].
    Volkova TD; Vol'pina OM; Ivanov VT; Rubin SG; Semashko IV; Karavanov AS
    Bioorg Khim; 1998 Feb; 24(2):100-11. PubMed ID: 10335405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative analysis on the physicochemical properties of tick-borne encephalitis virus envelope protein residues that affect its antigenic properties.
    Bukin YS; Dzhioev YP; Tkachev SE; Kozlova IV; Paramonov AI; Ruzek D; Qu Z; Zlobin VI
    Virus Res; 2017 Jun; 238():124-132. PubMed ID: 28625666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protein E 98-113 sequence is a fusion site of tick-borne encephalitis virus with cellular membrane].
    Volkova TD; Vol'pina OM; Ivanov VT; Vargin VV; Vorovich MF; Timofeev AV; Semenov BF; Tsekhanovskaia NA; Pressman EK
    Bioorg Khim; 1998 Sep; 24(9):676-81. PubMed ID: 9813732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
    Roehrig JT; Bolin RA; Kelly RG
    Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of quaternary organization on the antigenic structure of the tick-borne encephalitis virus envelope glycoprotein E.
    Kiermayr S; Stiasny K; Heinz FX
    J Virol; 2009 Sep; 83(17):8482-91. PubMed ID: 19553320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monoclonal antibody that recognizes the predicted tick-borne encephalitis virus E protein fusion sequence blocks fusion.
    Volkova TD; Vorovitch MF; Ivanov VT; Timofeev AV; Volpina OM
    Arch Virol; 1999; 144(5):1035-9. PubMed ID: 10416385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge.
    Goncharova E; Ryzhikov E; Poryvaev V; Bulychev L; Karpyshev N; Maksyutov A; Ryzhikov AB
    Int J Med Microbiol; 2006 May; 296 Suppl 40():195-201. PubMed ID: 16545605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model.
    Mandl CW; Guirakhoo F; Holzmann H; Heinz FX; Kunz C
    J Virol; 1989 Feb; 63(2):564-71. PubMed ID: 2463377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the antigenic structure of tick-borne encephalitis virus by the use of synthetic peptides.
    Holzmann H; Utter G; Norrby E; Mandl CW; Kunz C; Heinz FX
    J Gen Virol; 1993 Sep; 74 ( Pt 9)():2031-5. PubMed ID: 8376978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Location of immunodominant antigenic determinants on fragments of the tick-borne encephalitis virus glycoprotein: evidence for two different mechanisms by which antibodies mediate neutralization and hemagglutination inhibition.
    Heinz FX; Berger R; Tuma W; Kunz C
    Virology; 1983 Oct; 130(2):485-501. PubMed ID: 6196909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Localization of tick-borne encephalitis virus protein E antigenic determinant recognized by antihemagglutinating monoclonal antibodies using a phage-display peptide library].
    Loktev AV; Kuvshinov VN; Melamed NV; Ivanisenko VA; Mishin VP; Il'ichev AA
    Vopr Virusol; 2002; 47(2):31-4. PubMed ID: 12046465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Subunit immunogen of the tick-borne encephalitis virus. The immunological characteristics of glycoprotein V3 from 2 antigenic types of tick-borne encephalitis virus].
    Chumakov MP; Rubin SG; Kusov IuIu; Semashko IV; Sal'nikov IaA
    Vopr Virusol; 1984; 29(6):701-6. PubMed ID: 6528577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Change in the antigenic structure of surface glycoprotein E of tick-borne encephalitis virus during its adaptation to ticks and mammals].
    Romanova LIu; Gmyl' LV; Loktev VB; Protopopova EV; Dzhivanian TI; Lashkevich VA; Karganova GG
    Vopr Virusol; 2006; 51(6):31-4. PubMed ID: 17214080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering of Chimeric Protein Based on E Protein Domain III of Tick- Borne Encephalitis Virus and OmpF Porin of Yersinia pseudotuberculosis.
    Stenkova AM; Chopenko NS; Davydova LA; Mazeika AN; Bystritskaya EP; Portnyagina OY; Anastyuk SD; Kulbatskii DS; Lyukmanova EN; Dolgikh DA; Kostetsky EY; Sanina NM
    Protein Pept Lett; 2017; 24(10):974-981. PubMed ID: 28741465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tick-borne encephalitis virus envelope protein E-specific monoclonal antibodies for the study of low pH-induced conformational changes and immature virions.
    Holzmann H; Stiasny K; York H; Dorner F; Kunz C; Heinz FX
    Arch Virol; 1995; 140(2):213-21. PubMed ID: 7535997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Localization of the antigenic segment of the tick-borne encephalitis virus envelope protein using monoclonal antibodies].
    Tsekhanovskaia NA; Matveev LE; Pletnev AG; Rubin SG; Safronov IV; Pressman EK
    Bioorg Khim; 1991 Mar; 17(3):334-42. PubMed ID: 1712201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant domains III of Tick-Borne Encephalitis Virus envelope protein in combination with dextran and CpGs induce immune response and partial protectiveness against TBE virus infection in mice.
    Ershova AS; Gra OA; Lyaschuk AM; Grunina TM; Tkachuk AP; Bartov MS; Savina DM; Sergienko OV; Galushkina ZM; Gudov VP; Kozlovskaya LI; Kholodilov IS; Gmyl LV; Karganova GG; Lunin VG; Karyagina AS; Gintsburg AL
    BMC Infect Dis; 2016 Oct; 16(1):544. PubMed ID: 27717318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic immunoassays for tick-borne encephalitis virus based on recombinant baculovirus protein expression.
    Marx F; Gritsun TS; Grubeck-Loebenstein B; Gould EA
    J Virol Methods; 2001 Jan; 91(1):75-84. PubMed ID: 11164488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method for rapid and high-yield production of the tick-borne encephalitis virus E and DIII recombinant proteins in E. coli with preservation of the antigenic properties.
    Rizzo S; Mora-Cárdenas E; Faoro V; D'Agaro P; Edomi P; Marcello A; Sblattero D
    Ticks Tick Borne Dis; 2019 Jun; 10(4):935-941. PubMed ID: 31072731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.